McKinsey pays $650 million to settle opioid crisis probe

BREAKING: McKinsey has agreed to pay $650 million to settle a federal investigation into its work for opioid manufacturer Purdue Pharma. McKinsey documents describe Purdue using the consulting firm to help "turbocharge" opioid sales. www.cbsnews.com/news/mckinsey-opioids-settlement-federal-probe/

#Corruption - a huge problem in the Global North. “knowingly and intentionally conspiring with Purdue Pharma and others to aid and abet misbranding of prescription drugs” www.ft.com/content/18abc4a2-cd13-4b3f-92fe-276c349d9b17

Consultants McKinsey — which the Legault government used extensively during the pandemic — has agreed to pay the U.S. Justice Department $650 million for its role in "turbocharging" sales of Oxycontin that fueled the opioid epidemic that cost so many lives.www.nytimes.com/2024/12/13/business/mckinsey-oxycontin-settlement.html

McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid sales | AP News apnews.com/article/mckinsey-justice-department-criminal-penalty-opioids-crisis-d47d1bc1c4e14288927c2aea2369b789